PATHOGENETIC MECHANISMS AND TREATMENT PRINCIPLES OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

PATHOGENETIC MECHANISMS AND TREATMENT PRINCIPLES OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION

Data about chronic thromboembolic pulmonary hypertension (CTPH) prevalence is presented. The main CTPH clinical manifestations are described. The possible reasons and pathogenetic mechanisms of CTPH development are discussed. Features of unfavorable disease prognosis are also presented. Indications,...

Full description

Bibliographic Details
Main Authors: N. A. Shostak, A. A. Klimenko, N. A. Demidova, I. V. Novikov
Format: Article
Language:English
Published: Столичная издательская компания 2016-01-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
pulmonary hypertension
chronic thromboembolic pulmonary hypertension
thromboembolism of pulmonary artery
thromboendarterectomy
bosentan
prostacyclin analogues
phosphodiesterase-5 inhibitors
Online Access:https://www.rpcardio.online/jour/article/view/750

Internet

https://www.rpcardio.online/jour/article/view/750

Similar Items